Skip to main content
Account
Fig. 6 | Nanoscale Research Letters

Fig. 6

From: Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

Fig. 6

Breast cancer cell uptake of drugs loaded in PLV/DXR NPs. Fluorescence microscopy images of FITC-loaded PLV/DXR taken up by MDA-MB-231 (a) and MDA-MB-453 (b) cells at 0.5, 1, and 4 h (blue for DAPI, red for DXR, green for FITC). c Quantitative analysis of cellular uptake of DXR in MDA-MB-231 and MDA-MB-453 cells after PLV/DXR treatment

Back to article page

Navigation